These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 20154454)
1. One-year evaluation of combined treatment with an intranasal corticosteroid and montelukast for chronic rhinosinusitis associated with asthma. Nonaka M; Sakanushi A; Kusama K; Ogihara N; Yagi T J Nippon Med Sch; 2010 Feb; 77(1):21-8. PubMed ID: 20154454 [TBL] [Abstract][Full Text] [Related]
2. Lack of long-term add-on effect by montelukast in postoperative chronic rhinosinusitis patients with nasal polyps. Van Gerven L; Langdon C; Cordero A; Cardelús S; Mullol J; Alobid I Laryngoscope; 2018 Aug; 128(8):1743-1751. PubMed ID: 29114894 [TBL] [Abstract][Full Text] [Related]
3. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis. Di Lorenzo G; Pacor ML; Pellitteri ME; Morici G; Di Gregoli A; Lo Bianco C; Ditta V; Martinelli N; Candore G; Mansueto P; Rini GB; Corrocher R; Caruso C Clin Exp Allergy; 2004 Feb; 34(2):259-67. PubMed ID: 14987306 [TBL] [Abstract][Full Text] [Related]
4. Effect of the addition of montelukast to fluticasone propionate for the treatment of perennial allergic rhinitis. Esteitie R; deTineo M; Naclerio RM; Baroody FM Ann Allergy Asthma Immunol; 2010 Aug; 105(2):155-61. PubMed ID: 20674827 [TBL] [Abstract][Full Text] [Related]
5. Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast. Ratner PH; Howland WC; Arastu R; Philpot EE; Klein KC; Baidoo CA; Faris MA; Rickard KA Ann Allergy Asthma Immunol; 2003 May; 90(5):536-42. PubMed ID: 12775135 [TBL] [Abstract][Full Text] [Related]
10. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial). Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768 [TBL] [Abstract][Full Text] [Related]
11. Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control. Nathan RA; Yancey SW; Waitkus-Edwards K; Prillaman BA; Stauffer JL; Philpot E; Dorinsky PM; Nelson HS Chest; 2005 Oct; 128(4):1910-20. PubMed ID: 16236835 [TBL] [Abstract][Full Text] [Related]
12. Montelukast in the treatment of allergic rhinitis: an evidence-based review. Nayak A; Langdon RB Drugs; 2007; 67(6):887-901. PubMed ID: 17428106 [TBL] [Abstract][Full Text] [Related]
13. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma. Fritscher LG; Rodrigues MT; Zamel N; Chapman KR Respir Med; 2009 Feb; 103(2):296-300. PubMed ID: 18805684 [TBL] [Abstract][Full Text] [Related]
14. Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs. O'Connor RD; Stanford R; Crim C; Yancey SW; Edwards L; Rickard KA; Dorinsky P Ann Allergy Asthma Immunol; 2004 Dec; 93(6):581-8. PubMed ID: 15609769 [TBL] [Abstract][Full Text] [Related]
15. Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast. Jayaram L; Pizzichini E; Lemière C; Man SF; Cartier A; Hargreave FE; Pizzichini MM Thorax; 2005 Feb; 60(2):100-5. PubMed ID: 15681495 [TBL] [Abstract][Full Text] [Related]
16. Montelukast decreased exhaled nitric oxide in children with perennial allergic rhinitis. Hung CH; Hua YM; Hsu WT; Lai YS; Yang KD; Jong YJ; Chu YT Pediatr Int; 2007 Jun; 49(3):322-7. PubMed ID: 17532829 [TBL] [Abstract][Full Text] [Related]
17. [Fluticasone propionate aqueous nasal spray for the treatment of chronic sinusitis with eosinophil]. Ohta Y; Tsubaki K; Yamamoto M; Makino N; Ishikawa T; Ichimura K Nihon Jibiinkoka Gakkai Kaiho; 2006 Mar; 109(3):157-62. PubMed ID: 16615430 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of leukotriene receptor antagonism in the postoperative management of chronic rhinosinusitis. Yelverton JC; Holmes TW; Johnson CM; Gelves CR; Kountakis SE Int Forum Allergy Rhinol; 2016 Mar; 6(3):243-7. PubMed ID: 26834076 [TBL] [Abstract][Full Text] [Related]
19. Adding montelukast to fluticasone propionate/salmeterol for control of asthma and seasonal allergic rhinitis. Katial RK; Oppenheimer JJ; Ostrom NK; Mosnaim GS; Yancey SW; Waitkus-Edwards KR; Prillaman BA; Ortega HG Allergy Asthma Proc; 2010; 31(1):68-75. PubMed ID: 20167147 [TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory properties of montelukast, a leukotriene receptor antagonist in patients with asthma and nasal polyposis. Schäper C; Noga O; Koch B; Ewert R; Felix SB; Gläser S; Kunkel G; Gustavus B J Investig Allergol Clin Immunol; 2011; 21(1):51-8. PubMed ID: 21370724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]